Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Return on Capital Employed (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Return on Capital Employed for 2 consecutive years, with 0.71% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 38.0% to 0.71% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.71%, a 38.0% decrease, with the full-year FY2025 number at 0.57%, down 11.0% from a year prior.
  • Return on Capital Employed was 0.71% for Q4 2025 at Artiva Biotherapeutics, down from 0.58% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.33% in Q4 2024 to a low of 0.71% in Q4 2025.